Assignee
FORX THERAPEUTICS AG
CH·0 granted patents·3 pending applications·0 citations·filing 2022–2025
Top patents by PatentIndex Score
3 records- 0156US2025002491A1N,n-dimethyl-4-(7-(n-(1-methylcyclopropyl)sulfamoyl)-imidazo[1,5-a]pyridin-5-yl)piperazine-1-carboxamide derivatives and the corresponding pyrazolo[1,5-a]pyridine derivatives as parg inhibitors for the treatment of cancerFORX THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 0256US2026055106A1Parg inhibitory compoundFORX THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 0356US2024425498A1Parg inhibitory compoundsFORX THERAPEUTICS AG·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when FORX THERAPEUTICS AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →